Omega-3 Market by Type (DHA, EPA, & ALA), Source (Marine & Plant), Application (Dietary Supplements, Functional Foods & Beverages, Pharmaceuticals, Infant Formulas, and Pet Food & Feed), Form, Manufacturing Technology, and Region - Global Forecast to 2030

The omega-3 market is estimated to be USD 4,362.2 million in 2025 and is projected to reach USD 7,756.4 million by 2030, at a CAGR of 12.2%.

The omega-3 market is gaining significant traction, driven by the increasing recognition of the roles of EPA and DHA in cardiovascular health, cognitive function, vision, joint health, and infant brain development, as well as a growing consumer shift toward preventive healthcare and functional nutrition. The infant formula sector has witnessed explosive growth, driven by rising awareness among parents about the importance of early nutrition for cognitive and physical development, particularly the role of DHA and other essential nutrients, and regulatory mandates and recommendations in regions such as Europe, North America, and China requiring or encouraging DHA fortification in infant formula. However, high costs involved in R&D activities and unstable fish oil prices are expected to pose a challenge to the omega-3 market’s growth.

Disruptions in the omega-3 market may offer opportunities for players

The omega-3 market is undergoing fundamental shifts, opening up new opportunities for companies. One of the most significant changes is the shift toward sustainable and plant-based sources such as algal oil and fermentation-based omega-3, which eliminate fish oil supply concerns and resonate with vegan and green consumers. Regulatory updates, such as the mandatory fortification of DHA in infant nutrition and broader approvals for cardiovascular and cognitive well-being claims, are also driving steady demand in both developed and emerging markets. Meanwhile, technological advances such as microencapsulation are enhancing stability and flavor, allowing omega-3 to be incorporated in new food and beverage applications.

On the application front, Omega-3 is increasingly being used in pharmaceuticals, pet food, and aquaculture, apart from conventional supplements. Pharma-grade formulations for neurological and cardiovascular health are gaining momentum, while high-end pet food and fortified aquaculture feed are experiencing significant growth. Alongside growing demand for convenience formats of functional nutrition products (gummies, powders, RTDs) and increasing consumer spending on health supplement products in South America and the Asia Pacific, these trends are redefining the landscape of the market. Players who innovate in sourcing, product development, and sustainability have a good chance of securing growth in emerging markets.

The dietary supplement segment is projected to be one of the fastest-growing segments

The dietary supplement category is one of the major growth drivers for the omega-3 market as consumers place greater emphasis on preventive healthcare and turn to convenient solutions for heart, brain, eye, and joint well-being. Supported by regulatory approvals for health claims, supplements offer confidence and convenience, as advancements in delivery forms, such as softgels, gummies, and powders, make them attractive to people of all ages. This synergy of health consciousness, aging population, and product creativity is driving robust and consistent demand for omega-3 in dietary supplements.

The liquid form of omega-3 is expected to hold a larger share of the omega-3 market

The majority of commercial omega-3 comes from fish oil, algal oil, and krill oil, which are naturally liquid forms and commonly used in dietary supplements, infant formula, functional foods, and pharmaceuticals. Liquids can accommodate higher purity, greater bioavailability, and simpler inclusion in soft gels, emulsions, and fortified liquid food. While dry formulations (powders, microencapsulated Omega-3) are increasing as a result of uses in gummies, powders, and bakery applications, the liquid form continues to hold a significant market share as it is the most cost-efficient, mass-produced, and immediately applicable state across industries.

The Eicosapentaenoic Acid (EPA) segment is expected to grow at a significant rate

The EPA has been shown to benefit heart health, including reducing triglyceride levels, decreasing inflammation, and improving overall cardiovascular function. As awareness of these health benefits increases among consumers, there is a growing demand for omega-3 supplements and fortified foods and beverages containing EPA, which contributes to the expansion of the omega-3 market.

The US is estimated to dominate the North American omega-3 market during the forecast period

The US is one of the largest global markets for omega-3. The consumption of omega-3-based products and supplements has increased significantly due to rising consumer awareness of their various health benefits and their availability in the US market. The omega-3 consumption pattern in the US is driven toward categories such as capsules, dietary supplements, and infant formula. However, the country has one of the largest consumer markets in the world. Recently, the EPA/DHA (omega-3) ingredients sector has experienced a surge in product innovations, introducing new omega-3 variants and expanding the utilization of plant-based sources. As consumers increasingly prioritize the health of oceans, there is a growing demand for plant-based omega-3 ingredients within the dietary supplement sector.

In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the omega-3 market.

• By Company Type: Tier 1–25%, Tier 2–45%, and Tier 3–30%
• By Designation: CXOs–25%, Managers–40%, Executives–35%
• By Region: North America–22%, Europe–28%, Asia Pacific–32%, South America–10% and Rest of the World–8%

Prominent companies in the market include BASF SE (Germany), Cargill, Incorporated (US), dsm-firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International PLC (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture Inc. (Canada), GOLDEN OMEGA (Chile), Polaris (France), Btsa (Spain), KinOmega Biopharm Inc. (China), Rimfrost AS (Norway), Mara Renewables (Canada), Cellana Inc. (US), AlgaeCytes Limited (UK), and others.

Research Coverage

This research report categorizes the omega-3 market by type (Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid (EPA), and Alpha-linolenic Acid (ALA)), source (marine [fish, algal, krill, and other marine sources] and plant [nuts & seeds and vegetable oils]), application (dietary supplements, functional foods & beverages, pharmaceuticals, infant formulas, and pet food and feed), form (dry and liquid), manufacturing technology (qualitative) (extraction, refining & purification, concentration & conversion, encapsulation & stabilization, and fermentation & biotechnology), and region (North America, Europe, Asia Pacific, South America, and Rest of the World).

The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of omega-3 ingredients. A thorough analysis of the key industry players has been done to provide insights into their business, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments associated with the omega-3 market. This report covers the competitive analysis of upcoming startups in the omega-3 market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscapes, among others.

Reasons to Buy This Report

The report offers market leaders/new entrants information on the closest approximations of the revenue numbers for the overall omega-3 and subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

• Analysis of key drivers (Rising adoption of algal oil and plant-based omega-3 (flaxseed, chia, canola) due to concerns over fish oil sustainability), restraints (lack of clarity among consumers about daily recommended intake and health claims), opportunities (increase in research for development of alternative sources to obtain omega-3), and challenges (highly unstable fish oil prices) influencing the growth of the omega-3 market
• Product Development/Innovation: Detailed insights on research & development activities and new product launches in the omega-3 market
• Market Development: Comprehensive information about lucrative markets—the report analyzes omega-3 across varied regions
• Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the omega-3 market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as BASF SE (Germany), Cargill, Incorporated (US), dsm-firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International PLC (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), and other players in the omega-3 market.

Show more